REFI Earnings

REFI reported its earnings on 2026-05-07, showcasing a revenue of 13.12M against an estimate of 13.17M, resulting in a -0.35% surprise. The EPS was 0.42, surpassing the expected 0.44 by -4.55%. The stock experienced a -5.14% price change on the earnings day and a -7.1% change over the next five days, reflecting market reactions to the results.

Following REFI's earnings announcement on 2026-05-07, the stock price moved by -5.14% on the day of the release. Over the subsequent five days, it saw a -7.1% change. Historically, REFI's stock price tends to shift by an average of 0.31% in the 10 days leading up to earnings and -0.57% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate REFI's annual revenue to reach 14.50M, while the EPS is projected at 0.44. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between REFI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, REFI's stock price typically moves by 0.31% in the 10 days before its earnings and -0.57% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of 0.44 and revenue of 14.50M.

The earnings call presents a mixed sentiment. Financial performance shows some weaknesses, with decreased net interest income and increased interest expenses, but the company maintains a strong pipeline and strategic positioning in the cannabis sector. The Q&A reveals some uncertainties, particularly around specific loans and management's reluctance to provide detailed updates. The market sentiment is cautiously optimistic due to potential regulatory benefits and strategic moves, but the lack of clear guidance and rising leverage tempers positive expectations. Overall, the stock price is likely to remain stable, with no significant catalysts for strong movement.